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Mevalonate Pyrophosphate Decarboxylase is Predominantly Located 
in the Cytosol of both B16 and B16F10 Cells in 
Mouse Melanoma Treated with Lovastatin
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ABSTRACT: Recently, it has been a question whethers mevalonate pyrophosphate 
decarboxylase (MPD) is predominantly located in the peroxisomes or cytosol.  We previously 
reported that a small amount of MPD in rat liver fed a CP diet (5% cholestyramine and 
0.1% pravastatin) existed in the peroxisomes, although MPD is predominantly located in the 
cytosol in rat liver treated with normal chow and CP diet for 12 days.  In the present study, we 
examined the subcellular distribution of MPD in mouse melanoma cells (B16 and B16F10) 
treated with or without lovastatin, using digitonin permeabilization and immunoblotting. 
In permeabilized B16 by digitonin after treatment with or without lovastatin, 95% and 5%, 
or 98% and 2% of MPD existed in the cytosol and membrane/organelle (M/O) fraction, 
respectively.  Using B16F10 in the same conditions, 80% and 20%, or 91% and 9% of MPD 
existed in the cytosol and M/O fraction, respectively.  These results indicated that MPD was 
predominatly located in the cytosol in both mouse melanoma cells treated with or without 
lovastatin.
抄録　近年、メバロン酸二リン酸脱炭酸酵素（ＭＰＤ）の主要な局在場所において、
細胞質とペルオキシソームのどちらに多く存在しているか問題になっている。我々は
以前、ＭＰＤの多くは細胞質に存在し、プラバスタチンとコレスチラミンを含む餌を
ラットに摂取させた肝にのみ、少量のＭＰＤがペルオキシソームに存在することを示
した。今回の研究において、我々はロバスタチンをで処理したＢ１６とＢ１６Ｆ１０
細胞中のＭＰＤの細胞内分布を調査した。その結果、ロバスタチン処理未処理共に両
細胞において、細胞質に多くＭＰＤが存在することを明らかにした。
